The International Journal of Biochemistry & Cell Biology · 2015 · 44 citations · 24 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyOncogenesCancer Cell SignalingCancer ImmunotherapyOncogenic Signaling PathwaysSignal Transduction In CancerAcute Lymphoblastic Leukemia TherapyBcr-abl InhibitorsBcr-abl1 Fusion GeneCancer Cell Survival SignalingMtor InhibitionMtor Pathway DysregulationMtor SignalingPi3k-akt-mtor Signaling
24
Brian Druker, Charles L. Sawyers, Hagop M. Kantarjian et al. · New England Journal of Medicine · 2001 · 2.7K citations · Full text
Medicine, Hematology, Oncology +17
Tyrosine Kinase Activity and Transformation Potency of <i>bcr-abl</i> Oncogene Products
T G Lugo, Ann Marie Pendergast, Alexander J. Muller et al. · Science · 1990 · 1.3K citations
Anthony V. Moorman, Christine J. Harrison, Georgina Buck et al. · Blood · 2006 · 748 citations · Full text
Life Sciences, Hematology, Oncology +14
Kirk R. Schultz, W. Paul Bowman, Alexander Aledo et al. · Journal of Clinical Oncology · 2009 · 709 citations · Full text
Medicine, Hematology, Oncology +16